Shaping the Mammalian Cell Fermentation Technology Market Outlook in 2025: Advancements In Mammalian Cell Fermentation Technology And Market Outlook Dynamics

How Big Is the Mammalian Cell Fermentation Technology Market Expected to Be, and What Will Its Growth Rate Be?
Recent years have witnessed significant growth in the mammalian cell fermentation technology market. The market, which is projected to reach a size of $51.29 billion in 2024, is anticipated to grow further to $57.48 billion in 2025. This represents a compound annual growth rate (CAGR) of 12.1%. A few factors driving this growth during the previous period include a rising demand for biologics and biosimilars, a heightened focus on personalized medicine, increased production of biopharmaceuticals, and a surge in demand for scalable and efficacious cell culture methodologies.

The market size for mammalian cell fermentation technology is projected to experience swift expansion in the upcoming years, potentially reaching $89.54 billion by 2029 at a compound annual growth rate (CAGR) of 11.7%. The predicted growth during the forecast period is linked to several factors such as a higher incidence of chronic illnesses, multinational corporations increasing their investments, escalating frequency of persistent diseases, the growing acceptance of cutting-edge bioprocessing methods, a rise in investment for researching and developing new recombinant proteins, and increased demand for cancer treatment options. The primary trends projected for the forecast period are advancements in cell culture technology, improved designs for bioreactors, the development of next-gen bioprocessing technologies, multi-omics approach integration, and automation driven by technology.

What Factors Are Propelling the Expansion of the Mammalian Cell Fermentation Technology Market?
The mammalian cell fermentation technology market is projected to flourish due to the heightened demand for biologics. Biologics, medicinal products developed from living entities or their components, are commonly employed to manage diseases like cancer, autoimmune disorders, and infectious diseases. The amplifying demand for these effective treatment methods for common chronic illnesses such as cancer, along with regulatory approvals and escalating investment in research and development, are all contributing to the growth of the biotechnology sector. Mammalian cell fermentation technology is instrumental in the efficient production of intricate biologics, bridging the gap for the increasing demand for personalized and targeted therapeutics. The scalability, versatility, and high-quality protein production capacity of this technology pave the way for innovation in the biopharmaceutical industry. A case in point would be in February 2024, as per the National Library of Medicine, a medical library in USA, the Food and Drug Administration (FDA) approved 55 fresh drugs in 2023, with 29 being new chemical entities (NCEs) and 25 as new biological entities (NBEs). This indicates a 50% surge contrasted with the 37 approvals in 2022. Therefore, it can be concluded that the surge of demand for biologics bolsters the bacterial cell fermentation technology market's growth.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16473&type=smp

Who Are the Dominant Companies Influencing Mammalian Cell Fermentation Technology Market Trends?
Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc

How Is the Mammalian Cell Fermentation Technology Market Evolving?
Key players in the mammalian cell fermentation technology market are honing their focus on the creation of innovative technologies like mammalian cell culture to solidify their market standing. The technology of mammalian cell culture is instrumental across an array of sectors such as biomanufacturing, research and regenerative medicine, as it facilitates the manufacturing of functional cell or tissue analogs, vaccines and therapeutic proteins. For example, Syntegon, a biotech firm based in Germany, debuted its Modular Bioprocessing Platform (MBP) at Achema 2024 in June 2024, a solution crafted to address pressing challenges in the production of biopharmaceuticals. The platform provides a versatile, fully automated and all-inclusive solution for multiple uses, such as microbial and mammalian cell cultures, plasmid DNA, proteins, peptides, oligonucleotides, and recombinant vaccines. Adhering to the "made in Germany" standard, the MBP's modularity enables cost reductions and quicker lead times while retaining superior functionality and quality. The placement of all related technology outside the cleanroom in its prefabricated design enhances efficiency and eases maintenance.

What Are the Different Segmentations in the Mammalian Cell Fermentation Technology Market?
The mammalian cell fermentation technology market covered in this report is segmented -

1) By Type: Chinese Hamster ovary* Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation, Other Types
2) By Application: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes, Other Applications
3) By End-Use: Biopharmaceutical Companies, Contract Research Organizations And Contract Development and Manufacturing Organizations, Academic And Research Institutes

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/mammalian-cell-fermentation-technology-global-market-report

Which Region Is at the Forefront of the Mammalian Cell Fermentation Technology Market?
North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Mammalian Cell Fermentation Technology Global Market Report?

- Market Size Analysis: Analyze the Mammalian Cell Fermentation Technology Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Mammalian Cell Fermentation Technology Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Mammalian Cell Fermentation Technology Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Mammalian Cell Fermentation Technology Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16473

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.